Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.
about
Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesPancreatic neuroendocrine tumors: approach to treatment with focus on sunitinibNonfunctional neuroendocrine tumor of the pancreas: Case report and review of the literature.18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their typeInsulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer.
P2860
Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel medical therapies of rec ...... creatic neuroendocrine tumors.
@en
Novel medical therapies of rec ...... creatic neuroendocrine tumors.
@nl
type
label
Novel medical therapies of rec ...... creatic neuroendocrine tumors.
@en
Novel medical therapies of rec ...... creatic neuroendocrine tumors.
@nl
prefLabel
Novel medical therapies of rec ...... creatic neuroendocrine tumors.
@en
Novel medical therapies of rec ...... creatic neuroendocrine tumors.
@nl
P2093
P2860
P1476
Novel medical therapies of rec ...... ncreatic neuroendocrine tumors
@en
P2093
R B Erlich
R R Abraham
P2860
P2888
P356
10.1007/S10620-011-1854-0
P577
2011-09-22T00:00:00Z